BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 26739466)

  • 1. [Consensus on the diagnosis and treatment of cholestasis liver diseases].
    ; ; ; Lu LG
    Zhonghua Gan Zang Bing Za Zhi; 2015 Dec; 23(12):924-33. PubMed ID: 26739466
    [No Abstract]   [Full Text] [Related]  

  • 2. [Not Available].
    Blum HE
    Dtsch Med Wochenschr; 2016 Nov; 141(23):1676. PubMed ID: 27855455
    [No Abstract]   [Full Text] [Related]  

  • 3. [Guidelines on the management of cholestasis liver diseases (2021)].
    Chinese Society of Hepatology, Chinese Medical Association
    Zhonghua Nei Ke Za Zhi; 2021 Dec; 60(12):1075-1087. PubMed ID: 34856682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Guidelines on the management of cholestasis liver diseases (2021)].
    Chinese Society of Hepatology, Chinese Medical Association
    Zhonghua Gan Zang Bing Za Zhi; 2022 Mar; 30(3):253-263. PubMed ID: 35462480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neonatal cholestasis. New approaches to diagnostic evaluation and therapy.
    Shah HA; Spivak W
    Pediatr Clin North Am; 1994 Oct; 41(5):943-66. PubMed ID: 7936782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholestatic liver diseases in adults.
    McGill JM; Kwiatkowski AP
    Am J Gastroenterol; 1998 May; 93(5):684-91. PubMed ID: 9625109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxic liver injury and cholestasis in critically ill patients.
    Horvatits T; Trauner M; Fuhrmann V
    Curr Opin Crit Care; 2013 Apr; 19(2):128-32. PubMed ID: 23403733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholestatic liver diseases.
    Levy C
    Clin Liver Dis; 2013 May; 17(2):xiii-xiv. PubMed ID: 23540508
    [No Abstract]   [Full Text] [Related]  

  • 9. [Explanation of the 2013 Chinese expert consensus guidelines for the diagnosis and treatment of cholestatic liver disease].
    Xie W; Cheng J
    Zhonghua Gan Zang Bing Za Zhi; 2014 Jan; 22(1):20-3. PubMed ID: 24754086
    [No Abstract]   [Full Text] [Related]  

  • 10. [Chinese expert consensus guidelines for the diagnosis and treatment of cholestatic liver disease reached in 2013].
    Chinese Expert Committee on the Diagnosis and Treatment of Cholestasis Liver Disease
    Zhonghua Gan Zang Bing Za Zhi; 2014 Jan; 22(1):9-19. PubMed ID: 24754085
    [No Abstract]   [Full Text] [Related]  

  • 11. [Therapeutic apheresis as a therapeutic device for perioperative liver dysfunction].
    Usami M; Saitoh Y
    Nihon Rinsho; 1992 Jan; 50 Suppl():255-61. PubMed ID: 1578688
    [No Abstract]   [Full Text] [Related]  

  • 12. [Icterus and cholestasis].
    Friis-Liby I; Wallerstedt S; Marschall HU
    Lakartidningen; 2012 Nov 14-20; 109(46):2093-6. PubMed ID: 23259215
    [No Abstract]   [Full Text] [Related]  

  • 13. Total parenteral nutrition-related liver disease.
    Sokol RJ
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1997; 38(6):418-28. PubMed ID: 9473812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis and management of cholestatic liver disease.
    Heathcote EJ
    Clin Gastroenterol Hepatol; 2007 Jul; 5(7):776-82. PubMed ID: 17628332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholestatic liver disease.
    Gossard AA; Talwalkar JA
    Med Clin North Am; 2014 Jan; 98(1):73-85. PubMed ID: 24266915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Benign (idiopathic) recurrent intrahepatic cholestasis].
    Pirwitz B
    Pol Tyg Lek; 1975 Mar; 30(12):529-30. PubMed ID: 1118346
    [No Abstract]   [Full Text] [Related]  

  • 17. Neonatal cholestasis syndrome in India--a diagnostic and therapeutic challenge.
    Bhave SA; Bavdekar AR; Pandit AN
    Indian Pediatr; 1996 Sep; 33(9):753-62. PubMed ID: 9057403
    [No Abstract]   [Full Text] [Related]  

  • 18. [The Jirgl test n the differential diagnosis of liver diseases].
    Málaga Prado N
    An Fac Med Lima; 1966 Jun; 49(2):320-32. PubMed ID: 5989502
    [No Abstract]   [Full Text] [Related]  

  • 19. Small bowel dilation in children with short bowel syndrome is associated with mucosal damage, bowel-derived bloodstream infections, and hepatic injury.
    Hukkinen M; Mutanen A; Pakarinen MP
    Surgery; 2017 Sep; 162(3):670-679. PubMed ID: 28689603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of serum lipoproteid-X (LP-X) determination for the diagnosis of cholestasis in chronic liver diseases.
    Milewski B; Palynyczko Z
    Pol Med Sci Hist Bull (1973); 1975; 15(5-6):551-5. PubMed ID: 1228704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.